At the Curtin Health Innovation Research Institute (CHIRI), researchers, doctors, nutritionists and pharmaceutical scientists are advancing new treatments for major chronic diseases including Alzheimer’s disease, inflammatory disorders, heart disease and traumatic brain injuries. Cancer is a key focus, with Curtin a founding co-leader in the A$10.8 million Liver Cancer Research Centre.
Our strengths
Cancer
We’re researching interventions for age-associated cancers such as breast, pancreas and prostate cancer and melanoma, with a focus on how the immune system influences cancer risk and disease progression.
In addition, Curtin scientists in CHIRI’s Liver Cancer Research Centre are investigating how liver cells ‘talk’ to each other and stopping them from becoming cancerous. We aim to give oncologists more precision to create personalised treatment plans, matching each patient with a medication that targets specific tumour types.
Learn more:
Clinical research
We’re investigating ways to improve patient outcomes in a broad range of clinical areas, diseases and medical conditions, including maternal and children’s health, paediatric critical and intensive care, mental health, rural health, chronic disease management and pre-hospital emergency care.
This work has led to the development of a new paediatric early warning system for recognising and responding to paediatric clinical deterioration: the ESCALATION Project. Tested at multiple sites across WA, this system is now fully implemented at Perth Children’s Hospital and Broome Hospital, with implementation at other sites across WA planned.
Learn more:
Inflammation and infectious disease
In this space, we are developing ways to stop the decline in immune system function with ageing, using the immune system itself to treat arthritis and adult cancers. We’re improving immune function for the treatment of infection and muscle repair, and working with the Telethon Kids Institute on global malaria epidemiology.
We’re also working to improve clinical practice and healthcare outcomes in the area of wound healing, which often affects the elderly. Our research has provided a rich source of data and made significant economic and therapeutic impacts on skin tear prevention and management.
Learn more:
Neurodegenerative disorders
Researchers are exploring new approaches for the prevention and treatment of Alzheimer’s disease, where we’re hoping to significantly slow cognitive decline. We’re also mapping the journey of brain injury patients, from incident to integration back into the community, and taking a world-first approach to attenuate the burden associated with chronic migraine.
Learn more:
Vascular and metabolic disorders
Scientists at CHIRI are identifying new treatments for blood vessel disorders including bleeding and clotting disorders, heart disease and stroke, and investigating blood vessel growth and function to treat age-associated cancers, blood-vessel inflammatory disorders, energy disorders, liver disorders and infectious diseases.
One example is a collaborative team of bio-nanotechnology and drug development researchers within CHIRI who are identifying new therapies and drug delivery methods for the treatment of diabetes and other age-related diseases. The team uses nano-micro encapsulation technology to design innovative formulations capable of delivering drugs or pancreatic cells to treat diabetic patients.
Learn more:
Partner with us
By partnering with Curtin, you’ll gain access to a network of experts and specialised facilities that can help your business become more efficient, sustainable and profitable. There are also opportunities for investment, licensing, mentoring and employment.
Reach out to Curtin’s Research Partnerships Team using the form below.
Key people
Professor John Mamo
Professor Oliver Rackham
DISCIPLINES
Gene therapy and editing, Genetic engineering, Protein engineering, Synthetic biology, Systems biology.
Professor Ben Mullins
DISCIPLINES
Aerosols, Air pollutants, Droplets, Environmental health, Filters, Fluids, Occupational health, Particles, Respiratory health, Safety science.
Associate Professor Ryusuke Takechi
DISCIPLINES
Blood-brain barrier, Dementia, Diabetes, Inflammation, Neuroscience, Nutrition, Oxidative stress, Physiology, Vascular biology.
Professor Moira O’Connor
In the news
New $3M partnership to drive innovation in critical minerals sector
Curtin University has announced a new $3 million research collaboration with Mining Process Solutions (MPS), a division of Draslovka a.s.…
Boosting WA startups: Report calls for investment in talent, diversity and innovation
A new report from the Bankwest Curtin Economics Centre reveals Western Australia’s startup and innovation ecosystem requires targeted reforms and…
Curtin recognises excellence at Research and Engagement Awards
Curtin University has announced the winners of its 2024 Research and Engagement Awards, celebrating exceptional research and media engagement. The…
Curtin to bring industry together to improve the lives of people with disability
Curtin University is aiming to improve the lives of people with disability, by bringing key stakeholders from a wide range…